Evidence map›Paper›PMID 39951501›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Receptor clustering tunes and sharpens the selectivity of multivalent binding.

Zhaoping Xie, Stefano Angioletti-Uberti, Jure Dobnikar, Daan Frenkel, Tine Curk

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. The Reality of Active Targeting in Nanomedicine: Promise Versus Performance.Chembiochem : a European journal of chemical biology · 2026
    Review
  3. Review
  4. Article
  5. Multivalency Enables Signal Processing at Single Protein Level.Journal of the American Chemical Society · 2025
    Article
  6. Functional diversity in GII.4 norovirus entry: HBGA binding and capsid clustering dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhaoping XieDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Stefano Angioletti-UbertiDepartment of Materials, Imperial College London, London SW7 2AZ, United Kingdom.ORCID 0000-0003-2917-2415
Jure DobnikarChinese Academy of Sciences Key Laboratory of Soft Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China.ORCID 0000-0002-1169-6619
Daan FrenkelDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.ORCID 0000-0002-6362-2021
Tine CurkDepartment of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD 21218.ORCID 0000-0002-2167-5336

Funding

CAS | Chinese Academy of Sciences Key Project (CAS Key Project) XDB33000000MOST | National Natural Science Foundation of China (NSFC) 12034019NSF | ENG | Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) 2402407
6 · The paper itself

Abstract

The immune system exploits a wide range of strategies to combine sensitivity with selectivity for optimal response. We propose a generic physical mechanism that allows tuning the location and steepness of the response threshold of cellular processes activated by multivalent binding. The mechanism is based on the possibility to modulate the attraction between membrane receptors. We use theory and simulations to show how tuning interreceptor attraction can enhance or suppress the binding of multivalent ligand-coated particles to surfaces. The changes in the interreceptor attraction less than the thermal energy

Indexed as

Models, BiologicalReceptors, Cell SurfaceComputer SimulationEndocytosisLigandsProtein BindingLigandsReceptors, Cell SurfaceMonte Carlomultivalent bindingreceptor clusteringsuperselectivity

Identifiers

PMID39951501
PMCPMC11848318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.